Denali has entered a $275m royalty funding agreement with Royalty Pharma based on future net sales of tividenofusp alfa ...
Takeda and Innovent have closed their global partnership for next-generation IO and ADC therapies after fulfilment of ...
The pharma industry has called the IRA “price setting” and argues that the negotiations have not cut out-of-pocket costs for ...
The commissioners’ concerns are in response to sweeping vaccine regulation changes earmarked by CBER head Vinay Prasad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback